ArticleTrials2025

Methotrexate oral or subcutaneous for rheumatoid arthritis (MOOSE): study protocol for a multi-centre randomised trial.

Sarah McClure et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.